Table 3. Association of beclin 1 expression with patients’ clinicopathologic features in 41 patients with breast cancer.

Variable	Beclin 1 expression
	All Cases	Low	High	p Value
HER2 expression in total cases(41)				0.008
Negative	26	21(80.8%)	5(19.2%)
Positive	15	6(40.0%)	9(60.0%)
HER2 expression in ER positive cases(25)				0.002
Negative	18	16(88.9%)	2(11.1%)
Positive	7	1(14.3%)	6(85.7%)
HER2 expression in ER negative cases(16)				1.000
Negative	8	5(62.5%)	3(37.5%)
Positive	8	5(62.5%)	3(37.5%)